The experience of Visanne use in patients of reproductive age with external genital endometriosis
OA: bronze
CC0
AI-generated summary
This study examined the experience of Visanne use in reproductive-aged patients diagnosed with external genital endometriosis.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
My notes (saved in your browser only)
Condition tags
Citation neighborhood (2-hop)
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]
References (30)
- Clinical management of endometriosis via openalex
- Clinical Management of Endometriosis via openalex
- Clinical practice. Endometriosis via openalex
- Dienogest, a synthetic progestin, inhibits the proliferation of immortalized human endometrial epithelial cells with suppression of cyclin D1 gene expression via openalex
- Dienogest inhibits BrdU uptake with G0/G1 arrest in cultured endometriotic stromal cells via openalex
- Dienogest in the treatment of endometriosis-associated pelvic pain: a 12-week, randomized, double-blind, placebo-controlled study via openalex
- Dienogest is as effective as intranasal buserelin acetate for the relief of pain symptoms associated with endometriosis--a randomized, double-blind, multicenter, controlled trial via openalex
- Dienogest is as effective as triptorelin in the treatment of endometriosis after laparoscopic surgery: results of a prospective, multicenter, randomized study via openalex
- Dienogest is a selective progesterone receptor agonist in transactivation analysis with potent oral endometrial activity due to its efficient pharmacokinetic profile via openalex
- Effect of dienogest administration on angiogenesis and hemodynamics in a rat endometrial autograft model via openalex
- Effect of dienogest on endometrial morphology and function with external genital endometriosis via openalex
- ESHRE guideline for the diagnosis and treatment of endometriosis via openalex
- Evidence-based long-term management of endometriosis: Medical therapy and treatment of infertility via openalex
- Lipid metabolism during treatment of endometriosis with the progestin dienogest via openalex
- Long-term cyclic and continuous oral contraceptive therapy and endometrioma recurrence: a randomized controlled trial via openalex
- New progestagens for contraceptive use via openalex
- Pharmacodynamic study of four oral dosages of dienogest via openalex
- Reduced pelvic pain in women with endometriosis: efficacy of long-term dienogest treatment via openalex
- Treatment utilization for endometriosis symptoms: a cross-sectional survey study of lifetime experience via openalex
- 'Waiting for Godot': a commonsense approach to the medical treatment of endometriosis via openalex
- Why use of dienogest for the first contraceptive pill with estradiol? via openalex
- W6689513977 via openalex
- W2010311608 via openalex
- W2023365171 via openalex
- W2045458073 via openalex
- W2095424038 via openalex
- W2101417341 via openalex
- W2104687197 via openalex
- W2130203785 via openalex
- W99140794 via openalex
Source provenance
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0
· commercial use OK